Загрузка...
New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer
Poly (ADP-ribose) polymerase (PARP) inhibitors are a therapeutic milestone exerting a synthetic lethal effect in the treatment of cancer involving BRCA1/2 mutation. Theoretically, PARP inhibitors (PARPi) eliminate tumor cells by disrupting DNA damage repair through either PARylation or the homologou...
Сохранить в:
| Опубликовано в: : | Front Oncol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7724080/ https://ncbi.nlm.nih.gov/pubmed/33324554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.578095 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|